School of Medicine

New research led by Washington University researchers identifies a common genetic signature that may increase a person’s risk of developing substance use disorders. The work eventually could lead to universal therapies to treat multiple substance use disorders and potentially help people diagnosed with more than one.

New research from the School of Medicine’s Guoyan Zhao and colleagues provides guidance for future study to understand the role of glia in disease pathogenesis using mouse models. The work is published in Nature Aging.

Three early-career scientists who have conducted their research at Washington University School of Medicine in St. Louis have been honored with the Young Physician-Scientist Award by the American Society for Clinical Investigation (ASCI).

Michael Vahey at the McKelvey School of Engineering, will investigate how influenza virus proteins contribute to the spread of infection with a five-year, nearly $2 million grant from the National Institutes of Health (NIH).

Researchers at the School of Medicine have developed a new imaging method to produce detailed 3D maps of uterine contractions in real time. The technology could help define the progression of healthy labor and identify when problems may be developing, such as in preterm labor or labor arrest.

Rajendra S. Apte, MD, PhD, in the John F. Hardesty, MD, Department of Ophthalmology & Visual Sciences at the School of Medicine, has received the 2023 Ernst H. Bárány Prize from the International Society for Eye Research.

Eight physician-scientists at the School of Medicine have been elected members of the newest class of the American Society for Clinical Investigation.

A new study from researchers at the School of Medicine indicates that T cells play a key role in neurodegeneration related to the brain protein tau, a finding that suggests new treatment strategies for Alzheimer’s and related diseases.

Researchers at the School of Medicine have identified a way to sensitize metastatic breast cancer that has spread to bone to immunotherapy.

People who have had COVID-19 are at increased risk of developing gastrointestinal (GI) disorders within a year after infection, according to an analysis of federal health data by researchers at the School of Medicine and the Veterans Affairs St. Louis Health Care system.